Lexington Biosciences(LXGTF)
$0.000.00 (0.00%)
LXGTF
Lexington Biosciences financials statements
$0.00
At close:0.00 (0.00%)
Lexington Biosciences (LXGTF) Financial Statements
8 Followers
Lexington Biosciences Financial Overview
Lexington Biosciences's market cap is currently C$212.24K. The company's EPS TTM is C$-0.01; its P/E ratio is -0.02; Lexington Biosciences has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 |
| Gross Profit | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 |
| Operating Income | C$ -158.00K | C$ -173.48K | C$ -312.63K | C$ -459.50K | C$ -533.53K |
| EBITDA | C$ -168.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ -1.15M |
| Net Income | C$ -177.38K | C$ -175.00 | C$ -324.24K | C$ -480.00 | C$ -1.27M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 0.00 | C$ 0.00 | C$ 664.00 | C$ 27.64K | C$ 12.82K |
| Total Assets | C$ 0.00 | C$ 0.00 | C$ 664.00 | C$ 27.64K | C$ 12.82K |
| Total Debt | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 843.48K |
| Net Debt | C$ 0.00 | C$ 0.00 | C$ -664.00 | C$ -27.64K | C$ 830.65K |
| Total Liabilities | C$ 988.79K | C$ 811.41K | C$ 1.82M | C$ 1.52M | C$ 1.05M |
| Stockholders' Equity | C$ -988.79K | C$ -811.41K | C$ -1.82M | C$ -1.49M | C$ -1.04M |
| Cash Flow | |||||
| Free Cash Flow | C$ 0.00 | C$ -664.00 | C$ -26.97K | C$ -325.19K | C$ -210.27K |
| Operating Cash Flow | C$ 0.00 | C$ -664.00 | C$ -26.97K | C$ -325.19K | C$ -210.27K |
| Investing Cash Flow | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 |
| Financing Cash Flow | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 340.00K | C$ 115.77K |
Currency in CAD

